athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “overweight” rating reiterated by equities research analysts at Piper Jaffray Companies in a research note issued to investors on Friday, The Fly reports. They currently have a $171.00 price objective on the health services provider’s stock. Piper Jaffray Companies’ price target would indicate a potential upside of 9.66% from the stock’s current price. The analysts noted that the move was a valuation call.

A number of other research firms have also recently weighed in on ATHN. BidaskClub raised shares of athenahealth from a “hold” rating to a “buy” rating in a research note on Saturday, June 24th. Jefferies Group LLC reaffirmed a “hold” rating and set a $135.00 target price on shares of athenahealth in a research note on Monday, June 26th. William Blair reaffirmed a “market perform” rating on shares of athenahealth in a research note on Friday. J P Morgan Chase & Co set a $136.00 target price on shares of athenahealth and gave the stock a “hold” rating in a research note on Wednesday. Finally, SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $150.00 target price on shares of athenahealth in a research note on Monday. One analyst has rated the stock with a sell rating, fourteen have issued a hold rating and twelve have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $143.33.

athenahealth (ATHN) traded up 8.44% during midday trading on Friday, reaching $155.93. The company had a trading volume of 2,286,356 shares. athenahealth has a one year low of $90.11 and a one year high of $158.66. The company has a market capitalization of $6.21 billion, a PE ratio of 306.95 and a beta of 1.79. The stock’s 50 day moving average is $141.51 and its 200 day moving average is $122.62.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating the consensus estimate of $0.39 by $0.12. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The business had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. During the same period in the previous year, the business earned $0.34 earnings per share. The company’s revenue was up 15.0% on a year-over-year basis. Equities research analysts forecast that athenahealth will post $1.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “athenahealth, Inc. (NASDAQ:ATHN) Given Overweight Rating at Piper Jaffray Companies” was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/07/21/athenahealth-inc-nasdaqathn-given-overweight-rating-at-piper-jaffray-companies.html.

In other news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $140.52, for a total transaction of $562,080.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at approximately $44,939,279.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $109.48, for a total transaction of $32,844.00. The disclosure for this sale can be found here. Insiders sold a total of 26,105 shares of company stock valued at $3,394,859 over the last ninety days. 3.20% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ATHN. FNY Partners Fund LP increased its position in athenahealth by 1,900.0% in the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after buying an additional 950 shares during the period. Russell Investments Group Ltd. acquired a new position in athenahealth during the fourth quarter valued at approximately $118,000. Teza Capital Management LLC acquired a new position in athenahealth during the first quarter valued at approximately $220,000. Comerica Bank acquired a new position in athenahealth during the fourth quarter valued at approximately $299,000. Finally, Arxis Securities LLC acquired a new position in athenahealth during the first quarter valued at approximately $304,000.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

The Fly

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.